Metanovas Biotech
The AI engine Fit Assessment
BetaMetanovas effectively leverages machine learning and AI to enhance drug discovery, pattern discovery, and expand therapeutic options.
Blurb
Metanovas develops drugs, dietary supplements, functional foods, and cosmetics using AI technology.
HQ Location
Mountain View (United States)
Founded
2021
Employees
11 - 50
Total funding raised
$10.00M
Last Funding Event
Series A, December 3, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
- Biomarker Identification
Metanovas develops nutraceutical and cosmeceutical products with revolutionary AI technology. The company's product pipeline includes pharmaceuticals, nutritional supplements, functional foods, and cosmetics, providing patients and consumers with better goods. Metanovas alters how science and AI are used to generate health products.